Intermittent positive pressure breathing administration of terbutaline: a dose response study.
Eight patients with obstructive airways disease with a reversible component were treated with incremental doses of terbutaline by a Monaghan type nebulizer. Accumulative doses up to 3 mg were tolerated without significant side effects. Terbutaline appears to be safe and effective drug when administered by IPPB.
D000368:Aged; D000402:Airway Obstruction / Q000628:therapy*; D001794:Blood Pressure / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D005260:Female; D005541:Forced Expiratory Volume; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007384:Intermittent Positive-Pressure Breathing; D008297:Male; D008875:Middle Aged; D010366:Peak Expiratory Flow Rate; D011175:Positive-Pressure Respiration; D012129:Respiratory Function Tests; D013726:Terbutaline / Q000627:therapeutic use*; D014797:Vital Capacity
D013726:Terbutaline